FDA Clearance Tracker · P170013-S001
LVIS and LVIS Jr.
Last checked: Nov 20, 2026Latest source record: Nov 17, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Nov 17, 2020
Approved
Time to decision
845 days
Received Jul 26, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170013-S001
- Device name
- LVIS and LVIS Jr.
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Jul 26, 2018
- Decided
- Nov 17, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P170013
Device type
- Device type
- Intracranial coil-assist stent (QCA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.